Sanofi deepens NK cell therapy partnership with Innate PharmaTherapeuticsSanofi and Innate Pharma expand their longtime collaboration by licensing up to three NK cells engager programs in cancer immunotherapy valued at more than $1.4 billion. Read more December 19, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/05/Sanofi-to-sell-stake-in-Regeneron-Reuters-5-25-20.jpeg 246 370 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-12-19 10:36:172022-12-19 10:38:56Sanofi deepens NK cell therapy partnership with Innate Pharma
